Side Effects of Drugs Annual, Vol 28

  • ID: 1763348
  • Book
  • 694 Pages
  • Elsevier Science and Technology
1 of 4

Volume 28 in the series of Side Effects of Drugs Annuals ([external URL] continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction.

The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.

  • Provides a critical yearly survey of new data and trends
  • Includes an essay that describes the modern approach to classifying adverse drug reactions
  • Special reviews in this Annual include, among other topics: Antipsychotic drugs and now-onset diabetes mellitus, Treating asthma during pregnancy, and MMR vaccine and autism

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 4
Classifying adverse drug reactions in the 21st century
J.K. Aronson

1. Central nervous system stimulants and drugs that suppress appetite
R.P. Sequeira

2. Antidepressant drugs
P.J. Cowen

3. Lithium
D.L. Dunner

4. Drugs of abuse
J.K. Patel, Timothy E Ralston, and E.J. wong

5. Hypnotics and sedatives
S. Curran and S. Musa

6. Antipsychotic drugs
A. Carvajal,L.H. Martín Arias and Natalia Jimeno

7. Antiepileptic drugs
A. Gil-Nagel

8. Opioid analgesics and narcotic antagonists
A.H. Ghodse and A.M. Baldacchino

9. Anti-inflammatory and antipyretic analgesics and drugs used in gout
A. Del Favero

10. General anesthetics and therapeutic gases
Y. Young

11. Local anesthetics
S.A. Schug, P. Flisberg, S.A. Jackson, D.J. O'Connnor

12. Neuromuscular blocking agents and skeletal muscle relaxants
O. Zuzan and M. Leuwer

13. Drugs that affect autonomic functions or the extrapyramidal system
M. Schachter

14. Dermatological drugs and topical agents
S.R. Knowles, G. Wong, N.H. Shear

15. Antihistamines (H1 receptor antagonists)
G.M. Walsh

16. Drugs acting on the respiratory tract
M. Joerger, K. Hartmann, and M. Kuhn

17. Positive inotropic drugs and drugs used in dysrhythmias
J.K. Aronson

18. Beta-adrenoceptor antagonists and antianginal drugs
A.P. Maggioni, M.G. Franzosi, and R. Latini

19. Drugs acting on the cerebral and peripheral circulations
R. Verhaeghe

20. Antihypertensive drugs
P. Joubert

21. Diuretics
D.A. Sica

22. Metals
G.B. van der Voet and F.A. de Wolff

23. Metal antagonists
R.H.B. Meyboom

24. Antiseptic drugs and disinfectants
P. Magee

25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
T. Midtvedt

26. Miscellaneous antibacterial drugs
A. Imhof

27. Antifungal drugs
A.H. Groll, H. Kolve, and T.J. Walsh

28. Antiprotozoal drugs
J. Buser, K. Fattinger

29. Antiviral drugs
P.L. Vernazza, P. Schmid

30. Drugs used in tuberculosis and leprosy
S. Swaminathan

31. Antihelminthic drugs
P.J.J. van Genderen

32. Vaccines
S. Dittmann

33. Blood, blood components, plasma and plasma products
P.J.M. Vossebeld, P. Stangers and W.G. van Aken

34. Formulations used in nutrition
M.C. Allwood and G. Hardy

35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis
D. Keeling and J.K. Aronson

36. Gastrointestinal drugs
S. Dar, H.N. Dalton

37. Drugs that act on the immune system: cytokines and monoclonal antibodies
T.Vial, J. Descotes, C. Ludwig, and M. Behrend

38. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
F. Braun and M. Behrend

39. Corticotrophins, corticosteroids, and prostaglandins
J. Costa and M. Farré

40. Sex hormones and related compounds, including hormonal contraceptives
M.N.G. Dukes

41. Thyroid hormones iodine, and antithyroid drugs. J.A. Franklyn

42. Insulin, glucagon, and hypoglycemic drugs
H.M.J. Krans

43. Miscellaneous hormones
R. Page

44. Drugs that affect lipid metabolism
I. Aursnes

45. Cytostatic drugs
Hans-Peter Lipp, Jörg Thomas Hartmann, and Andrew Stanley

46. Radiological contrast agents
S.K. Morcos

47. Drugs used in ocular treatment
B.C.P. Polak

48. Treatments used in complementary and alternative medicine
E. Ernst

49. Miscellaneous drugs and materials, medical devices and techniques
N.H. Choulis and J.K. Aronson
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown